MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) announced that it will host a conference call to discuss its Q2 2020 financial results and provide a business update at 8:30 a.m. on Friday, August 14, 2020.
The company will issue a pre-market earnings announcement the same day. Investors are invited to participate on the call using the following details:
Dial-In Number: (844) 873-7330 (U.S.) or (602) 563-8473 (international)
Conference ID: ID 5587104
Webcast: Available in the “Investors” section of the Ocugen website at https://ir.ocugen.com/ and archived for approximately 45 days following the call
Ocugen, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing transformative therapies to cure blindness diseases.
Thanks for visiting! MyChesCo brings reliable information and resources to Chester County, Pennsylvania. Please consider supporting us in our efforts. Your generous donation will help us continue this work and keep it free of charge. Show your support today by clicking here and becoming a patron.